News

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell TherapyLONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc ...
GenVivo Highlights GEN2 Phase 1 Data and GEN-1013 Preclinical Data at the 2025 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting
GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial.GEN-1013 was studied in aggressive murine cancer models ...
Mass photometry technique speeds up quality control in gene therapy vector production
Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...
Design Better: How Abstract Thinking And Intuition Drive Brand Innovation
Real innovation rarely emerges from linear thinking. The best ideas arise when our minds either drift purposefully or operate ...